Lu Zhang

机构：Xidian University, Chinese Academy of Medical Sciences & Peking Union Medical College, China University of Mining and Technology, National Health and Family Planning Commission, Peking Union Medical College Hospital, Shandong Provincial Hospital, Public Health Clinical Center of Chengdu, Central Hospital of Zibo, Jinan City People's Hospital, Shandong First Medical University · ORCID：0000-0002-0860-9625

发表论文 162 篇 · 总被引 3098 次 · h-index 28

代表论文

• Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry (2025 · Blood Advances · 被引 19)
• Efficacy and safety of orelabrutinib in relapsed/refractory idiopathic multicentric Castleman disease: A single‐centre, retrospective study (2024 · British Journal of Haematology · 被引 8)
• The impact of carbon emissions trading policy on employment: Evidence from enterprises and cities (2025 · Journal of Cleaner Production · 被引 7)
• Unicentric Castleman disease complicated with bronchiolitis obliterans: A single‐centre retrospective study from China (2024 · British Journal of Haematology · 被引 6)
• Asymptomatic multicentric Castleman disease: a potential early stage of idiopathic MCD (2024 · Blood Advances · 被引 6)
• Successful treatment of relapsed idiopathic multicentric Castleman disease–idiopathic plasmacytic lymphadenopathy with orelabrutinib monotherapy: A case report (2024 · British Journal of Haematology · 被引 5)